Yahoo
OTC Markets OTCPK - Delayed Quote USD

Igene Biotechnology, Inc. (IGNE)

0.0000 0.0000 (0.00%)
At close: November 6 at 4:00:00 PM EST
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
Total Revenue
4.8040
Cost of Revenue
-36.0430
Gross Profit
40.8470
Operating Expense
637.9030
Operating Income
-597.0560
Net Non Operating Interest Income Expense
-64.5510
Other Income Expense
22.2920
Net Income Common Stockholders
-2,373.8830
Diluted NI Available to Com Stockholders
-2,373.8830
Basic EPS
0.00
Diluted EPS
0.00
Basic Average Shares
1,563,414.5010
Diluted Average Shares
1,563,414.5010
Total Operating Income as Reported
-2,331.6240
Total Expenses
601.8600
Net Income from Continuing & Discontinued Operation
-2,373.8830
Normalized Income
-2,388.3728
Interest Expense
64.5510
Net Interest Income
-64.5510
EBIT
-597.0560
EBITDA
-458.0640
Reconciled Cost of Revenue
-36.0430
Reconciled Depreciation
138.9920
Net Income from Continuing Operation Net Minority Interest
-2,373.8830
Total Unusual Items Excluding Goodwill
22.2920
Total Unusual Items
22.2920
Normalized EBITDA
-480.3560
Tax Rate for Calcs
0.0004
Tax Effect of Unusual Items
7.8022
-

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: